Market Research Logo

Global Rett Syndrome Market: Industry Analysis & Outlook (2017-2025)

Global Rett Syndrome Market: Industry Analysis & Outlook (2017-2025)

Rett syndrome is a rare genetic neurological disorder. This genetic disorder affects females exclusively due to the presence of X chromosome, and is rarely seen in boys. Male children are less prone to this disorder because boys with mutations in MECP2 hardly survive till birth. Changes in MECP2 typically occur during spermatogenesis, and such changes are usually on the paternal copy of the X-chromosome.

The symptoms of Rett syndrome generally occur after 12 months of birth and include signs like slow growth, loss of normal movement and coordination, abnormal hands and eyes movements, and breathing problems. Other drastic symptoms also develop with age. This disorder generally occurs in stages and fourth stage is said to be its last stage. Rett syndrome has no cure and is often treated with off-label drugs which prove to give no relief to the affected patient. Few pharmaceuticals companies are realizing the need for target specific drugs and many therapeutics are being developed, which are in their clinical phases.

The global Rett syndrome market will grow over the years driven by increase in female population, rising spending on public healthcare programs, and increasing global healthcare expenditure. The major trends and developments of the market include efforts to use gene therapy to rectify this neurological disorder, development of new drugs and use of more efficient technologies. However, growth of the market is challenged by factors like high cost of treatment and high R&D expenditure.

The report “Global Rett Syndrome Market: Industry Analysis & Outlook (2017-2025)” analyzes the development of this market, with focus on Sarizotan drug and its market opportunities. The major players are: Newron Pharmaceuticals, Neurem Pharmaceuticals Limited, Anavex Life Sciences Corp., Neuroloxis, and Edison Pharmaceuticals.


1. Market Overview
1.1 Rett Syndrome
1.2 Signs and Symptoms
1.3 Stages of Rett Syndrome
1.4 Causes of Rett Syndrome
1.5 Diagnosis and Treatment
2. Global Market Analysis
2.1 Global Rett Syndrome Prevalence
2.1.1 Global Rett Syndrome Prevalence by Region
Table 1: Global Rett Syndrome Prevalence by Region (2016)
2.1.2 Global Rett Syndrome Prevalence Share by Region
Table 2: Global Rett Syndrome Prevalence Share by Region (2016)
2.2 Global Rett Syndrome Incidence
Table 3: Global Rett Syndrome Incidence (2016)
2.3 Global Sarizotan Drug Market
2.3.1 Global Sarizotan Drug Market Forecast by Value
Table 4: Global Sarizotan Drug Market Forecast by Value (2018-2025)
2.3.2 Global Sarizotan Drug Market Forecast by Region
Table 5: Global Sarizotan Drug Market Forecast by Region (2025)
3. Regional Analysis
3.1 Europe’s Rett Syndrome Patient Volume Forecast
Table 6: Europe’s Rett Syndrome Patient Volume Forecast (2016-2025)
3.2 Europe’s Rett Syndrome Population with Breathing Disorder
Table 7: Europe’s Rett Syndrome Population with Breathing Disorder (2016-2025)
3.3 Europe’s Rett Syndrome Patient Diagnosis Rate
Table 8: Europe’s Rett Syndrome Patient Diagnosis Rate (2016-2025)
3.4 Europe Sarizotan Drug Market
3.4.1 Europe’s Sarizotan Drug Market Forecast by Value
Table 9: Europe’s Sarizotan Drug Market Forecast by Value (2018-2025)
3.4.2 Europe’s Sarizotan Drug Treatment by Patient Volume
Table 10: Europe’s Sarizotan Drug Treatment by Patient Volume (2018-2025)
3.5 The US Rett Syndrome Patient Volume Forecast
Table 11: The US Rett Syndrome Patient Volume Forecast (2016-2025)
3.6 The US Rett Syndrome Population with Breathing Disorder
Table 12: The US Rett Syndrome Population with Breathing Disorder (2016-2025)
3.7 The US Rett Syndrome Patient Diagnosis Rate
Table 13: The US Rett Syndrome Patient Diagnosis Rate (2016-2025)
3.8 The US Sarizotan Drug Market
3.8.1 The US Sarizotan Drug Market Forecast by Value
Table 14: The US Sarizotan Drug Market Forecast by Value (2018-2025)
3.8.2 The US Sarizotan Drug Treatment by Patient Volume
Table 15: The US Sarizotan Drug Treatment by Patient Volume (2018-2025)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Female Population Worldwide
Table16: Global Female Population (2012-2016)
4.1.2 Rising Spending on Public Health Programs for Females
4.1.3 Increased Spending on Medicines
Table 17: Global Spending on Medicines (2010-2020E)
Table 18: Total Spending on Medicines in the US (2012-2016)
4.1.4 Increasing Global Healthcare Expenditure
Table 19: Global Healthcare Expenditure (2012-2016)
4.2 Trends and Developments
4.2.1 Gene Therapy for Rett Syndrome
4.2.2 Development of New Drugs
Table 20: Major Drugs for Rett Syndrome in their Development Phases (2016)
4.2.3 Development of More Efficient and Advanced Technology
4.3 Issues and Challenges
4.3.1 High Cost of Treatment
4.3.2 High R&D Costs
4.3.3 Drug Progress Challenges in Developing Countries
5. Competitive Landscape
5.1 Global Rett Syndrome Market
5.1.1 Major Companies Comparison by Drug Segments
Table 21: Major Companies Comparison by Drug Segments (2016)
5.1.2 Comparison by Market Cap
Table 22: Comparison by Market Cap (2016)
6. Company Profiles
6.1 Newron Pharmaceuticals
6.1.1 Business Overview
Table 23: Clinical Pipeline of Newron Pharmaceuticals (2016)
6.1.2 Financial Overview
Table 24: Newron Pharmaceuticals Revenue and Net Loss (2012-2016)
6.1.3 Business Strategies
6.2 Neuren Pharmaceuticals Limited
6.2.1 Business Overview
Table 25: Neuren Pharmaceuticals Limited’s Product Pipeline (2016)
6.2.2 Financial Overview
Table 26: Neuren Pharmaceuticals Operating Revenue and Net Loss (2013-2016)
6.2.3 Business Strategies
6.3 Anavex Life Sciences Corp.
6.3.1 Business Overview
Table 27: Anavex Life Sciences Corp.’s Clinical Pipeline with Drug Candidates (2016)
6.3.2 Financial Overview
Table 28: Anavex Life Sciences Corp. Operating Expenses and Net Loss (2014-2016)
6.3.3 Business Strategies
6.4 Neuroloxis
6.4.1 Business Overview
Table 29: Neuroloxis’s Drug Developments (2016)
6.5 Edison Pharmaceuticals
6.5.1 Business Overview
Table 30: Edison Pharmaceutical’s Drug Pipeline (2016)
Table 31: Edison Pharmaceutical’s Clinical Developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report